Author

Marina Chiara Garassino

Observed names: Garassino, Marina Chiara, Marina Garassino

Institution: University of Chicago

Observed institution: University of Chicago

OpenAlex ID: A5135635689

Clinical-stage AI-enabled therapeutic assets: An industry-wide analysis of scale, clinical progression, and company characteristics.

2026 · Waqas Haque, Kareena Sai-Palm, et al. · Journal of Clinical Oncology · 2

OA01.05: A Novel Deep Learning Model for Automated Classification of Thymic Epithelial Tumors

2026 · Rishi Sharma, Matteo Sacco, et al. · Journal of Thoracic Oncology

PP01.28: Treatment Sequencing of Tepotinib in Patients With MET Exon 14 (METex14) Skipping Non-Small Cell Lung Cancer (NSCLC): Outcomes From ≥3 Years Follow-Up of the VISION Study

2026 · Paul K. Paik, Enriqueta Felip, et al. · Journal of Thoracic Oncology

PP01.27: Tepotinib in Patients with MET Exon 14 (METex14) Skipping Non-Small Cell Lung Cancer (NSCLC) From the VISION Study: ≥3-Year Follow-Up Outcomes

2026 · Paul K. Paik, Remi Veillon, et al. · Journal of Thoracic Oncology

OA01.03: Uncovering Hidden Risk: The Role of Family History in Lung Cancer Among Women and Low-Exposure Smokers

2026 · Sulin Wu, Alessandra Esposito, et al. · Journal of Thoracic Oncology

PP01.39: Outcomes with First-Line Adagrasib with Pembrolizumab in Patients With KRASG12C-Mutated Non-Small Cell Lung Cancer (NSCLC), Including Analysis by Programmed Death Ligand 1 (PD-L1) Expression, from the Phase 2 Portion of the KRYSTAL-7 Study

2026 · Marina Chiara Garassino, Pasi A. Jänne, et al. · Journal of Thoracic Oncology

PP01.79: Stable Isotope Labeling to Identify Metabolic Alterations Supporting Treatment Resistance in EGFR-Mutated NSCLC

2026 · Robert B. Cameron, Marina Garassino, et al. · Journal of Thoracic Oncology

Works count: 8

Citation count: 2

H-index: 1

I10-index: